tiprankstipranks
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress ReleasesPhathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2M ago
Phathom Pharmaceuticals reports Q4 EPS ($1.39), consensus ($1.08)
PremiumThe Fly
Phathom Pharmaceuticals reports Q4 EPS ($1.39), consensus ($1.08)
2M ago
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
PremiumPress Releases
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
2M ago
Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
PremiumPress ReleasesPhathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
3M ago
Needham ups Phathom target, adds to Conviction List as top 2024 pick
PremiumThe Fly
Needham ups Phathom target, adds to Conviction List as top 2024 pick
4M ago
Phathom expands existing loan, security agreement with Hercules Capital
PremiumThe Fly
Phathom expands existing loan, security agreement with Hercules Capital
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100